For many decades, since the discovery and exploration of oil in the Niger Delta of Nigeria, oil spillage has been a recurring health, ...

DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

In total, India now has seven universities in Asia’s top 100, 20 in the top 200, and 66 in the top 500, reflecting the ...

Seoul National University of Science and Technology announced on November 4 that 25 of its researchers have been named to the ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

First Healthcare Compliance, a division of Panacea Healthcare Solutions, and Med USA will co-host a complimentary live webinar, "Compliance Cliffs: Navigating the End of Telehealth Waivers and ...

EMQ, the world's leading provider of open-source MQTT messaging and IoT data infrastructure, today announced the Preview launch of EMQX Tables, a fully managed time-series database natively integrated ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Totipotent Cells: Often regarded as the "holy grail" of stem cell biology, these cells can develop into any type of cell in the body, offering vast possibilities for tissue regeneration.

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Qure (QURE) shares have taken a hit after the FDA withdrew support for using Phase I/II data from its AMT-130 Huntington's disease gene therapy in a key regulatory submission. This unexpected shift ...